Cite
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer.
MLA
Apolo, Andrea B., et al. “Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer.” JAMA Oncology, vol. 5, no. 12, Dec. 2019, pp. 1790–98. EBSCOhost, https://doi.org/10.1001/jamaoncol.2019.4114.
APA
Apolo, A. B., Milowsky, M. I., Kim, L., Inman, B. A., Kamat, A. M., Steinberg, G., Bagheri, M., Krishnasamy, V. P., Marko, J., Dinney, C. P., Bangs, R., Sweis, R. F., Maher, V. E., Ibrahim, A., Liu, K., Werntz, R., Cross, F., Beaver, J. A., Singh, H., … Agrawal, S. (2019). Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer. JAMA Oncology, 5(12), 1790–1798. https://doi.org/10.1001/jamaoncol.2019.4114
Chicago
Apolo, Andrea B, Matthew I Milowsky, Lauren Kim, Brant A Inman, Ashish M Kamat, Gary Steinberg, Mohammadhadi Bagheri, et al. 2019. “Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer.” JAMA Oncology 5 (12): 1790–98. doi:10.1001/jamaoncol.2019.4114.